Delia Goletti

Delia Goletti is the Head of the Translational Research Unit at the National Institute for Infectious Diseases L. Spallanzani in Rome, Italy.
She is Professor of Pathology, at Unicamillus University, Roma, Italy.
Her current research interests are on the immune pathogenesis, immune diagnostic tests and immune response to tuberculosis, echinococcosis and COVID-19. She is among the most cited scientists worldwide for COVID-19 and for tuberculosis research (https://expertscape.com/ex/covid-19/c/eur; https://expertscape.com/ex/tuberculosis ).

She has been working with Dr Anthony Fauci for 4 years at NIH in Bethesda, Maryland on the immune pathogenesis of HIV and HIV-TB coinfection.
Professor Goletti is the chair of the ESCMYC group (working on Mycobacteria) at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID).

She collaborated with World Health Organization (WHO) and European Respiratory Society (ERS) on tuberculosis elimination and advocacy, as well as with the New Diagnostics Working Group Task Force on tests for progression of latent infection to active disease supported by WHO and FIND.
She is the co-chair of the group working on conventional T cells within the “Collaboration for TB Vaccine Discovery” (CTVD) supported by the Bill and Melissa Gates Foundation.